Melanoma vaccine trial reveals promising results

A health story from New York, reported by WGRZ Buffalo.

Health · New York · October 27, 2026

From WGRZ Buffalo

A new personalized mRNA vaccine for melanoma, developed by Merck and Moderna, showed a 42% reduction in recurrence and death risk sparking hope for broader treatment

Reported by WGRZ Buffalo, October 27, 2026. Read the full story at WGRZ Buffalo →

More health from New York

Top Vatican official says Pope Leo's cancer is a ‘game-changer' for the papacy · NBC New York
Addiction treatment leaders discuss kratom dangers, opioid crisis at UR · RochesterFirst
Catholic Health planning $28.5M Northtowns medical hub · WGRZ Money
Halloween safety: doctors warn parents about injury and poisoning risks · WGRZ Buffalo
The role AI might play in your next doctor’s visit · RochesterFirst
Fourth-time New York City Marathon runner Smita Rajgopal on mental health advocacy and purpose · amNewYork
Police: Staff member injured in assault at Monroe Community Hospital · RochesterFirst
CDC's chief medical officer resigns after being hired in April · ABC7 NY

All health → · New York local news →

Open HeyHomees →